DNA content as a prognostic marker in patients with oral leukoplakia.
about
Oral Leukoplakia as It Relates to HPV Infection: A ReviewGenomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancerDNA index determination with Automated Cellular Imaging System (ACIS) in Barrett's esophagus: comparison with CAS 200Biomarkers of head and neck cancer, tools or a gordian knot?Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.Toward the use of precision medicine for the treatment of head and neck squamous cell carcinomaMolecular changes in the multistage pathogenesis of head and neck cancerDNA study of bladder papillary tumours chemically induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in Fisher ratsThe framework of pathology: good laboratory practice by quantitative and molecular methods.Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma.Incidence of Data Duplications in a Randomly Selected Pool of Life Science Publications.RETRACTED: Novel management of oral cancer: a paradigm of predictive oncology.Correlation of DNA ploidy with progression of cervical cancerOral squamous cell cancer: early detection and the role of alcohol and smoking.Molecular biology of squamous cell carcinoma of the head and neckApplication of cytology and molecular biology in diagnosing premalignant or malignant oral lesionsApoptosis regulation in tetraploid cancer cells.Impact of genomic instability in risk assessment and chemoprevention of oral premalignancies.Oral lichen planus and malignant transformation: is a recall of patients justified?Oral mucosal dysplastic lesions and early squamous cell carcinomas: underdiagnosis from incisional biopsy.Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics.Nipple aspirate fluid and ductoscopy to detect breast cancerMechanisms of disease: Inflammatory mediators and cancer prevention.Oral premalignancy: new methods of detection and treatmentSaliva--a pivotal player in the pathogenesis of oropharyngeal cancer.TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival.Chemopreventive potential of natural compounds in head and neck cancerDetection of cell carcinogenic transformation by a quadruplex DNA binding fluorescent probeRepression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinomaAn insight into salivary markers in oral cancer.The hamster cheek pouch model for field cancerization studies.Epithelial cell proliferative activity and oral cancer progression.Cell transformation and the evolution of a field of precancerization as it relates to oral leukoplakia.The expression of E-cadherin and cathepsin-D in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma: A comparative analysis between immunohistochemistry and routine histopathology.Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57KIP2 immunohistochemistry.Immunohistochemical analysis of acetylation, proliferation, mitosis, and apoptosis in tumor xenografts following administration of a histone deacetylase inhibitor--a pilot study.Head and neck cancer: a screening strategy.Ploidy analysis of field cancerization and cancer development in the hamster cheek pouch carcinogenesis model.Cytologic and DNA-cytometric examination of oral lesions in lichen planus.Cell proliferation and DNA content in rat urothelial lesions after repeat intravesical instillations of mitomycin C and bacillus Calmette-Guérin.
P2860
Q21285037-6556E471-076D-4CBC-9F12-04954F675B01Q24675639-90F13878-7EBC-439A-96F3-64166DF81DFAQ24812030-EAEB677D-7418-47DB-8011-A3C96A4F22F1Q26784289-20018EC7-73F7-4BF4-BD37-7F819ADA64B7Q27824854-DF332B55-4C23-42A7-9624-6AA19E6A1E4BQ28074691-B689302A-E7D6-4982-9805-050034FDA092Q28728638-96250A0F-694B-4B0B-A88C-BC1EE419BA0EQ28757383-C0892616-34BC-4D35-8B28-272A0B6323E2Q30862047-EDDC19D8-27C2-4C44-BCE3-130ABDC1CACFQ30903640-1EB45532-AD9D-4BA0-AB5D-C03658FCEA2AQ30969930-A70EF6BD-8A7C-428D-8D71-8E58AC2F3AE9Q33723572-B9DE2F33-9646-4C51-BDBD-D92E05771A8BQ33807648-2803B08A-CD5C-44D5-BD6D-37EED9186B20Q34500198-FFE041D9-133D-43F2-93C2-8CE493A8AAFBQ34518716-E020ABE1-BE9B-4BED-8FCD-33F721FE004DQ34567480-57002F26-524A-441F-8AE7-5FB0380FBC76Q34676609-4932B246-86C5-440F-BC33-CC56BDE2643DQ34810915-81DBEBC8-CFF1-410E-A031-CFB40288C56AQ34977313-DC599F70-2C77-4A0E-A3D5-BEFC46EF3E5EQ35092115-E605FE76-303D-45AF-8870-22CA59C73BBCQ35134845-90310554-5759-4214-BAA9-1743186CDAEFQ36079196-857A1AFA-C59C-4C48-8690-3A08B7745A93Q36303978-E25FA843-1721-470C-9EEA-F6889F2AD81EQ36409243-672360A8-078B-47B7-ABC1-1A6C3FAF1F49Q36626012-A760703F-177B-4B68-A33A-AE2905494C79Q36696616-1C135D26-DE88-436B-AF53-6682040595EEQ37097045-A452ACA6-87B7-407C-83D4-44220B9CA515Q37525196-206D558A-64E1-4B88-B548-1602D1299183Q37679199-5EBF2E22-79E9-44B3-AF56-A47A69FDA512Q38135818-E3446BDB-3CFB-4172-8841-32F8E5A6301AQ38286152-D9FE6A08-177A-4627-B084-994DAFE08F35Q38455889-25A843C1-1C7A-4634-9E7B-D40B899A3FBDQ38658437-97A5CC0B-6333-4E12-8B17-A3C952321739Q39481530-66571822-5BA8-4C43-86AD-8C902AAFB265Q39665815-CC50F7E2-0F74-449F-93B2-40053618AF30Q40334140-453669E8-9ED0-447F-B998-6A8EC0A11503Q44033141-D54BC45A-A2FB-4D6F-8F44-5A979DFFC223Q45308030-CA04687D-9232-4354-8449-DAB041D3F4DEQ46977515-B82F76CF-A1BB-4A99-96EA-B09D205C7172Q53504311-78304151-0E63-4E3E-92B6-996FD58851C3
P2860
DNA content as a prognostic marker in patients with oral leukoplakia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
DNA content as a prognostic marker in patients with oral leukoplakia.
@en
DNA content as a prognostic marker in patients with oral leukoplakia.
@nl
type
label
DNA content as a prognostic marker in patients with oral leukoplakia.
@en
DNA content as a prognostic marker in patients with oral leukoplakia.
@nl
prefLabel
DNA content as a prognostic marker in patients with oral leukoplakia.
@en
DNA content as a prognostic marker in patients with oral leukoplakia.
@nl
P2093
P1476
DNA content as a prognostic marker in patients with oral leukoplakia.
@en
P2093
P304
P356
10.1056/NEJM200104263441702
P407
P577
2001-04-01T00:00:00Z